Covestor’s Moderna MRNA Stock Holding History

Covestor’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15K	Sell	302 -194	-39%	-$9.05K	0.01%	1231
2025 Q4	$15K	Buy	496 +55	+12%	+$1.49K	0.01%	1401
2025 Q3	$11K	Sell	441 -7	-2%	-$195	0.01%	1548
2025 Q2	$12K	Buy	448 +170	+61%	+$4.48K	0.01%	1479
2025 Q1	$8K	Buy	278 +3	+1%	+$106	0.01%	1629
2024 Q4	$11K	Buy	275 +117	+74%	+$5.59K	0.01%	1492
2024 Q3	$11K	Buy	158 +2	+1%	+$184	0.01%	1501
2024 Q2	$19K	Sell	156 -257	-62%	-$32.5K	0.01%	1221
2024 Q1	$44K	Sell	413 -272	-40%	-$27.4K	0.03%	930
2023 Q4	$68K	Sell	685 -630	-48%	-$53K	0.05%	715
2023 Q3	$136K	Buy	1,315 +1,152	+707%	+$129K	0.1%	262
2023 Q2	$20K	Buy	163 +26	+19%	+$3.47K	0.02%	1139
2023 Q1	$21K	Sell	137 -12	-8%	-$1.98K	0.02%	986
2022 Q4	$27K	Sell	149 -137	-48%	-$22.4K	0.02%	948
2022 Q3	$34K	Sell	286 -971	-77%	-$147K	0.03%	847
2022 Q2	$179K	Buy	1,257 +58	+5%	+$8.29K	0.15%	139
2022 Q1	$207K	Buy	1,199 +836	+230%	+$141K	0.14%	143
2021 Q4	$92K	Buy	+363	New	+$106K	0.13%	202

Other funds holding MRNA

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return